Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

216.32 -0.61 (-0.28%)
Streaming Delayed Price Updated: 10:45 AM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Amgen

< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Dogs Of The Dow Lose Ground To Market Since First Quarter
The Dow Dogs remain in the performance derby with five months left in 2021. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Carter Worth And Mike Khouw's Amgen Trade
Carter Worth and Mike Khouw teamed up on CNBC's "Options Action" to give the viewers a bearish trade in Amgen, Inc. (NASDAQ: AMGN) ahead of earnings. Worth analyzed... 
Via Benzinga
3 Must-Own Healthcare Stocks For Your Portfolio
Healthcare stocks have had a steady run so far this year, with the industry’s growth prospects—based on ongoing digitization to revolutionize and increase demand—motivating investors. Thus, we believe... 
Via Talk Markets
Healthcare Stock Sell-Off Keeps the Dow Jones From Reaching Record Levels
A handful of healthcare giants are some of the few Dow stocks in the red so far today, as federal data underpins the prospects of a continued economic recovery. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc... 
Via Benzinga
Exposures COVID-19
Where Amgen Stands With Analysts
Within the last quarter, Amgen (NASDAQ:AMGN) has observed... 
Via Benzinga
Amgen Buys Antibody Player Focused On PSMA In $2.5B Deal
Amgen Inc (NASDAQ: AMGN) has agreed to acquire privately-held Teneobio, a biotechnology company developing a new class of biologics called Human Heavy-Chain... 
Via Benzinga
Dissecting the Dow Jones – 10 Attractively Valued Stocks
Only 10 of 30 stocks are attractively valued blue-chip stocks making up the Dow Jones Industrial Average (DJIA) today. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Healthcare ETFs in Focus as Q2 Earnings Unfold
Let’s dig deeper into the earnings picture of the companies which will drive the performance of healthcare funds in the coming days. 
Via Talk Markets
How To Find Value Stocks July 2021
Identifying fair value in an inflated stock market is really important, because in all markets, whether bull or bear you can always find value. 
Via Talk Markets
Benchmarks Extend Gains Amid Strong Day for Earnings
The Dow closed 286 points higher today, erasing Monday's sell-off as reopening stocks continue to climb, while the S&P 500 and Nasdaq finished the day in the black as well. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Boeing And Chevron Soar As The Dow Jones Finishes Higher
U.S. indices were trading higher as stocks continue to rebound following Monday’s weakness and as investors weigh recent earnings. Inves... 
Via Benzinga
Topics Stocks
Exposures US Equities
Moderna Stock — Soon To Join S&P 500 — Rockets To Yet Another Record
Moderna stock rocketed to another record high Friday on news it would join the S&P 500 on Wednesday, replacing soon-to-be-acquired Alexion. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Ahead Of AdComm AstraZeneca, FibroGen's Roxadustat Hit With Safety, Efficacy Questions
Ahead of Thursday's meeting of the FDA's Cardiovascular and Renal Drugs Advisory Committee, the agency is raising fresh doubts on the safety of AstraZeneca Plc's... 
Via Benzinga
Exposures Product Safety
BeiGene-Amgen's Kyprolis Gets Approval In China For Pre-Treated Multiple Myeloma Patients
The China National Medical Products Administration (NMPA) has conditionally approved Kyprolis (carfilzomib) for relapsed or refractory (R/R) multiple myeloma. The... 
Via Benzinga
The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc... 
Via Benzinga
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:... 
Via Benzinga
Topics Product Recall
Exposures COVID-19 Legal Product Safety
How Does Amgen's Debt Look?
Over the past three months, shares of Amgen (NASDAQ:AMGN) moved lower by nan%. Before having a look at the importance of debt, let us look at how much debt Amgen has. Amgen... 
Via Benzinga
Amgen - AstraZeneca's Asthma Candidate Under Priority Review With FDA
The FDA has accepted for review Amgen Inc's (NASDAQ: AMGN) marketing application seeking approval for tezepelumab to treat asthma. Amgen is developing... 
Via Benzinga
Exposures Product Safety
Here's Why Biohaven Pharmaceutical Is Soaring Today
Preliminary sales figures for the company's new migraine drug were much better than expected. 
Via The Motley Fool
Exposures Product Safety
Biohaven Stock Hits Record High As Migraine Drug Trounces Quarterly Forecasts
Biohaven crushed Wall Street's expectations for second-quarter sales of migraine drug Nurtec on Tuesday, leading BHVN stock to pop. 
Via Investor's Business Daily
The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Good Medicine at Bargain Prices
The pandemic has provoked a rethinking of pharma-biotech in our society. 
Via Talk Markets
Amgen Pumps $365M Into New Ohio Facility
Amgen Inc (NASDAQ: AMGN) plans to build a $365 million pharmaceutical packaging facility in New Albany that will employ 400 workers. The Ohio Tax Credit... 
Via Benzinga
14 Biotech Stocks To Watch Over The Next 6 Months
Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks. A case in point was the strong upside in Biogen Inc.'s (NASDAQ:... 
Via Benzinga
Which Is A Better Investment? Amgen Vs Bristol-Myers Squibb… The Winner May Surprise You
Both companies have the same yield, at right about 2.9%. They've also both been increasing their dividends for almost the same exact length of time - 12 years for Bristol-Myers Squibb versus 11 years... 
Via Talk Markets
This Stock Should Be On Your Radar: It’s Selling At A 10% Discount And Rated A “Buy”
There’s a common misperception among investors. This misperception is that you have to look far and wide for great long-term investment ideas. It’s as if blue-chip companies that are household names... 
Via Talk Markets
The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
2 Top Dividend Stocks You Can Buy and Hold Forever
Both of these companies raised their dividend payouts even amid the pandemic. 
Via The Motley Fool
Topics Economy
Exposures Economy
Should You Buy Biotech ETFs Now?
Instead of trying to pick winners in this volatile space, it is better to invest in broader biotech ETFs that stand to benefit from increased investor interest and rising spending on drugs and... 
Via Talk Markets
< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.